当前位置: X-MOL 学术Sci. Signal. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Biased signaling by thyroid-stimulating hormone receptor–specific antibodies determines thyrocyte survival in autoimmunity
Science Signaling ( IF 6.7 ) Pub Date : 2018-01-23 , DOI: 10.1126/scisignal.aah4120
Syed A. Morshed 1 , Risheng Ma 1 , Rauf Latif 1 , Terry F. Davies 1
Affiliation  

The thyroid-stimulating hormone receptor (TSHR) is a heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptor (GPCR). Autoimmune hyperthyroidism, commonly known as Graves’ disease (GD), is caused by stimulating autoantibodies to the TSHR. We previously described TSHR-specific antibodies (TSHR-Abs) in GD that recognize linear epitopes in the cleavage region of the TSHR ectodomain (C-TSHR-Abs) and induce thyroid cell apoptosis instead of stimulating the TSHR. We found that C-TSHR-Abs entered the cell through clathrin-mediated endocytosis but did not trigger endosomal maturation and failed to undergo normal vesicular sorting and trafficking. We found that stimulating TSHR-Abs (S-TSHR-Abs) activated Gαs and, to a lesser extent, Gαq but that C-TSHR-Abs failed to activate any of the G proteins normally activated in response to TSH. Furthermore, specific inhibition of G proteins in the presence of S-TSHR-mAbs or TSH resulted in a similar failure of endosomal maturation as that caused by C-TSHR-mAbs. Hence, whereas S-TSHR-mAbs and TSH contributed to normal vesicular trafficking of TSHR through the activation of major G proteins, the C-TSHR-Abs resulted in GRK2- and β-arrestin-1–dependent biased signaling, which is interpreted as a danger signal by the cell. Our observations suggest that the binding of antibodies to different TSHR epitopes may decrease cell survival. Antibody-induced cell injury and the response to cell death amplify the loss of self-tolerance, which most likely helps to perpetuate GPCR-mediated autoimmunity.



中文翻译:

甲状腺刺激激素受体特异性抗体的偏向信号决定了自身免疫中甲状腺细胞的存活

促甲状腺激素受体(TSHR)是异三聚体鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体(GPCR)。自身免疫性甲状腺功能亢进症,通常称为Graves病(GD),是由刺激TSHR的自身抗体引起的。我们先前在GD中描述了TSHR特异性抗体(TSHR-Abs),该抗体识别TSHR胞外域(C-TSHR-Abs)裂解区域中的线性表位,并诱导甲状腺细胞凋亡而不是刺激TSHR。我们发现C-TSHR-Abs通过网格蛋白介导的内吞作用进入细胞,但未触发内体成熟,并且未进行正常的囊泡分选和运输。我们发现,刺激TSHR-ABS(S-TSHR-ABS)活化Gα小号和,在较小程度上,Gα q但是C-TSHR-Abs未能激活任何正常响应TSH激活的G蛋白。此外,在S-TSHR-mAbs或TSH存在下对G蛋白的特异性抑制导致内体成熟的失败与C-TSHR-mAbs引起的相似。因此,尽管S-TSHR-mAbs和TSH通过激活主要G蛋白促进了正常TSHR的囊泡运输,但C-TSHR-Abs导致了GRK2和β-arrestin-1依赖性偏向信号传导,这被解释为牢房发出危险信号。我们的观察结果表明抗体与不同TSHR表位的结合可能会降低细胞存活率。抗体诱导的细胞损伤和对细胞死亡的反应会加剧自我耐受性的丧失,这很可能有助于使GPCR介导的自身免疫永存。

更新日期:2018-01-24
down
wechat
bug